OncoNet Rhein-Main e. V.
The OncoNet Rhein-Main is a network of clinics, molecular pathology laboratories, practices and medical centers that aims to provide effective and targeted care to all cancer patients in the Rhein-Main area. Working together, partners in the network support clinical studies to integrate innovative therapy approaches into daily clinical practice.
Charité Institute of Pathology
The Institute of Pathology at the Charité Berlin is a key player in the care of cancer patients of the country’s capital and surrounding area. Their broad spectrum of analytical methods covers histological, cytological, and molecular diagnostics to deliver the reliable and timely identification of therapeutic options.
Gen Era Diagnostics
Gen Era Diagnostics is a leading provider of molecular diagnostics products and services in Turkey. The company has empowered scientists, clinicians, and laboratories in the investigation of diseases and the treatment of patients since 2013 with a comprehensive offering of cutting-edge research and diagnostic technologies.
Molecular Health and Gen Era Diagnostics agree to collaborate in the field of precision oncology in Turkey
Molecular Health and the life science company Gen Era Diagnostics have signed a collaboration agreement to optimize the personalized treatment of patients with cancer. For this purpose, Gen Era will provide the MH Guide software platform to twenty laboratories in Turkey to use in the interpretation of tumor data.
The potential of liquid biopsies for early cancer detection powered by ONCOCATCH and MH Guide
Molecular Health will join partner EONE-Diagnomics Genome Center (EDGC) in the EDGC seminar “Liquid biopsy for early detection of multiple cancers and Molecular Health GmbH introduction” on Wednesday, 13 October at 16:00–17:00 Korean Standard Time (GMT+9).
MH Guide 5.0: Software for therapy planning in precision oncology, now available with a comprehensive update
Molecular Health has launched the latest version of its analysis software MH Guide. This software, which is used by pathology laboratories and molecular tumor boards, now has improved search capabilities to identify patient- relevant clinical studies.
What’s new in MH Guide version 5.0
MH Guide Version 5.0 was published with some new features in terms of handling and functionality. Read more here …
Molecular Health and Korean EONE-Diagnomics Genome Center (EDGC) join forces in liquid biopsy-based precision medicine
The collaboration is intended to establish leadership in the fast-growing precision medicine market for liquid biopsy.
Molecular Health and Universitätsmedizin Essen [Essen University Hospital] launch collaborative project to improve care for COVID-19 patients
Pioneering project to use clinical data with evidence-based disease model for better diagnosis and therapy in Germany.
Konyang University Hospital in South Korea relies on MH Guide for personalized cancer medicine
Konyang University Hospital in Daejeong, South Korea, will rely on MH Guide in the personalized treatment of its cancer patients. This is the result of an agreement between the hospital and Molecular Health.